Novo Nordisk’s big hope green-lighted in the US

New diabetes product could be its golden egg

It’s been tough goings for Novo Nordisk in the US recently. But finally the Danish pharmaceutical giant has something to smile about across the Atlantic.

Yesterday, the US Food and Drug Administration (FDA) approved Semaglutide, the Novo Nordisk product designed to improve glycaemic control in adults with type 2 diabetes.

“This is going to mean the world for Novo Nordisk. This product has massive potential within the treatment of diabetes,” Søren Løntoft Hansen, an analyst with Sydbank, told Børsen newspaper.

“This has the potential to make up the spine of Novo Nordisk’s turnover and profit looking ten years ahead.”

READ MORE: Lego and Novo Nordisk among most desirable companies to work for in Denmark

Billions on the line
Some 16 out of 17 members of the FDA expert panel voted in favour of approving Semaglutide, while the final member abstained. Final approval is expected to come on December 5.

Information collected by Bloomberg News indicates that Semaglutid sales are expected to rake in more than 2 billion kroner in 2018 and increase to 11.6 billion kroner in 2020.

The good news comes just days after Novo Nordisk was ranked one of the most desirable companies to work for by university students in Denmark.

TOP STORIES

  • Danish Intelligence Service: Threat from Russia has intensified

    Danish Intelligence Service: Threat from Russia has intensified

    In the internal Danish waters, Russia will be able to attack underwater infrastructure from all types of vessels. The target could be cables with data, electricity and gas, assesses the Danish Defense Intelligence Service

  • Denmark to explore screening citizenship applicants for anti-democratic sentiments

    Denmark to explore screening citizenship applicants for anti-democratic sentiments

    A few weeks after Alex Vanopslagh’s comments about “right values,” the government announced that an expert committee would be established to examine the feasibility of screening citizenship applicants for anti-democratic attitudes.

  • The Future Copenhagen

    The Future Copenhagen

    The municipality plan encompasses building 40,000 houses by 2036 in order to help drive real estate prices down. But this is not the only huge project that will change the shape of the city: Lynetteholmen, M5 metro line, the Eastern Ring Road, and Jernbanebyen will transform Copenhagen into something different from what we know today

  • It’s not you: winter depression is affecting many people

    It’s not you: winter depression is affecting many people

    Many people in Denmark are facing hard times marked by sadness, anxiety, and apathy. It’s called winter depression, and it’s a widespread phenomenon during the cold months in Nordic countries.

  • Crime rates are rising, but people are safer

    Crime rates are rising, but people are safer

    Crime in Denmark is increasing for the second consecutive year, but it is more focused on property, while people appear to be safer than before. Over the past year, there were fewer incidents of violence

  • Novo Nordisk invests 8.5 billion DKK in new Odense facility

    Novo Nordisk invests 8.5 billion DKK in new Odense facility

    Despite Novo’s announcement that its growth abroad will be larger than in Denmark, the company announced this morning an 8.5 billion DKK investment for a new facility in Odense. This is the first time the company has established a new production site in Denmark this century.

Connect club

Connect Club is your gateway to a vibrant programme of events and an international community in Denmark.

Sign up here

Career

Want to advertise your job with CPH Post?

Contact us

Jobs